Abatacept for Patients With COVID-19 and Respiratory Distress
Status:
Withdrawn
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This is a single-arm open label trial for hospitalized patients with COVID-19 (Coronavirus).
The primary endpoint of the study is to assess the requirement for mechanical ventilation in
patients who are admitted to the hospital with COVID-19 infection and a Pulse Oxygen Level
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborators:
Boston Children's Hospital Boston Children’s Hospital Brigham and Women's Hospital Bristol-Myers Squibb